The doxycycline paradox in mitochondrial disease
Sep 02, 2022•20 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Expanding on their recent editorial, Shamima Rahman, Eva Morava and Tamas Kozicz discuss the doxycycline paradox and why a medication previously thought to be toxic might present an avenue for treatment in some primary mitochondrial disorders.
The doxycycline paradox in primary mitochondrial diseases
Tamas Kozicz, Shamima Rahman, and Eva Morava
https://doi.org/10.1002/jimd.12531
For the best experience, listen in Metacast app for iOS or Android